Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Novo’s diabetes treatment semaglutide gets unanimous FDA backing

October 19, 2017
Sales and Marketing Novo Nordisk, diabetes, semaglutide

Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one …

News
diabetes-777001_960_720

Sanofi plans summit to tackle diabetes in 5 million Nigerian citizens

October 17, 2017
Manufacturing and Production, Medical Communications Nigeria, Sanofi, WHO, diabetes, pharma

Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million …

News
jj

J&J exits insulin pump business, rival looks to scoop patients

October 10, 2017
Manufacturing and Production Johnson & Johnson, biotech, diabetes, drugs, pharma, pharmaceutical

Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …

News

Sanofi promotes global head of diabetes to expand role

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

Appointment

Novo’s Xultophy beats basal insulin in cutting cardiovascular risk

September 14, 2017
Research and Development Novo Nordisk, Xultophy, diabetes, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has unveiled new data on its diabetes treatment Xultophy (insulin degludec/liraglutide) which supports its efficacy in reducing risk …

News
novo_flag

Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million

September 6, 2017
Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical

Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …

News
novo_flag

Novo diabetes drug outperforms Lilly rival at Phase 3

August 17, 2017
Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …

News
baby-1151345_960_720

Less sleep in children linked to increased risk of diabetes

August 16, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical, type 2, type-2

A study emerging from St George’s University of London found that children who slept an hour less than the recommended …

News
energy-bar-snack-chocolate-bar-chocolate-candy-1636220

‘Hugely disturbing’ rise in UK children with type 2 diabetes, report finds

August 14, 2017
Medical Communications, Sales and Marketing childhood obesity, diabetes, healthcare, life sciences, obesity, pharma, pharmaceuticals

A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Merck, NICE, Parkinson's, biotech, diabetes, pharma, pharmaceutical, top ten

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …

News

Pioneering immunotherapy halts progression of type 1 diabetes

August 10, 2017
Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical

In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …

News
brain-1845962_960_720

Diabetes drug holds promise to slow Parkinson’s progression

August 4, 2017
Medical Communications, Research and Development Parkinson's disease, biotech, diabetes, drugs, pharma, pharmaceutical

There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …

News
shutterstock_339308225

Revealing the missing evidence: Randomised real-life studies in basal insulin therapy

July 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …

Feature
blood-1813410_960_720

‘Vaccine’ to lower cholesterol enters human trials

June 20, 2017
Manufacturing and Production, Research and Development AFFiRis, cholesterol, diabetes

After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …

News
vaccine

Reversal of type 1 diabetes possible through century-old vaccine

June 14, 2017
Research and Development BCG, Type 1 diabetes, Vaccine, diabetes

The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026